Stacy E. Croteau

2.2k total citations
66 papers, 1.4k citations indexed

About

Stacy E. Croteau is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Stacy E. Croteau has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 11 papers in Genetics and 8 papers in Internal Medicine. Recurrent topics in Stacy E. Croteau's work include Hemophilia Treatment and Research (49 papers), Platelet Disorders and Treatments (20 papers) and Blood Coagulation and Thrombosis Mechanisms (18 papers). Stacy E. Croteau is often cited by papers focused on Hemophilia Treatment and Research (49 papers), Platelet Disorders and Treatments (20 papers) and Blood Coagulation and Thrombosis Mechanisms (18 papers). Stacy E. Croteau collaborates with scholars based in United States, Canada and Italy. Stacy E. Croteau's co-authors include Cameron C. Trenor, Steven J. Fishman, John B. Mulliken, Harry P. Kozakewich, Ahmad I. Alomari, Jan Hartmann, Marilyn G. Liang, Arash Mahajerin, Margaret V. Ragni and Robert F. Sidonio and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Pediatrics.

In The Last Decade

Stacy E. Croteau

65 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stacy E. Croteau United States	19	748	399	327	223	179	66	1.4k
H. Aubert France	13	218 0.3×	136 0.3×	80 0.2×	112 0.5×	28 0.2×	68	714
Gavivann Veerakul Thailand	14	238 0.3×	68 0.2×	132 0.4×	177 0.8×	48 0.3×	34	744
Siobhán Glavey Ireland	15	305 0.4×	63 0.2×	135 0.4×	495 2.2×	19 0.1×	44	902
Emiko Sakaida Japan	17	373 0.5×	160 0.4×	186 0.6×	121 0.5×	26 0.1×	103	866
Pilar Solves Spain	18	463 0.6×	206 0.5×	96 0.3×	145 0.7×	33 0.2×	73	896
Narendranath Epperla United States	17	115 0.2×	116 0.3×	452 1.4×	90 0.4×	50 0.3×	147	1.0k
Jun Deng China	15	141 0.2×	39 0.1×	340 1.0×	247 1.1×	87 0.5×	37	714
Frank G. H. Hill United Kingdom	14	744 1.0×	73 0.2×	65 0.2×	130 0.6×	81 0.5×	24	1.0k
Ying‐Chou Chen Taiwan	15	198 0.3×	121 0.3×	173 0.5×	147 0.7×	18 0.1×	57	866
W. Beau Mitchell United States	18	417 0.6×	62 0.2×	34 0.1×	129 0.6×	54 0.3×	40	681

Countries citing papers authored by Stacy E. Croteau

Since Specialization

Citations

This map shows the geographic impact of Stacy E. Croteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy E. Croteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy E. Croteau more than expected).

Fields of papers citing papers by Stacy E. Croteau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy E. Croteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy E. Croteau. The network helps show where Stacy E. Croteau may publish in the future.

Co-authorship network of co-authors of Stacy E. Croteau

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy E. Croteau. A scholar is included among the top collaborators of Stacy E. Croteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy E. Croteau. Stacy E. Croteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ito, Satoko, Robert Bona, Harlan M. Krumholz, et al.. (2025). Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis. Blood Advances. 9(24). 6237–6245. 1 indexed citations

Mrakotsky, Christine, Karin S. Walsh, Stacy E. Croteau, et al.. (2024). The eTHINK Study: Cognitive and Behavioral Outcomes in Children with Hemophilia. The Journal of Pediatrics. 272. 114089–114089.

Mancuso, Maria Elisa, Stacy E. Croteau, & Robert Klamroth. (2024). Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies. Haemophilia. 30(S3). 39–44. 11 indexed citations

Jaffray, Julie, Brian R. Branchford, Neil A. Goldenberg, et al.. (2023). Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children’s Hospital Acquired Thrombosis consortium. Journal of Thrombosis and Haemostasis. 21(9). 2441–2450. 2 indexed citations

Young, Guy, Peter J. Lenting, Stacy E. Croteau, Beatrice Nolan, & Alok Srivastava. (2023). Antithrombin-lowering in hemophilia: a closer look at fitusiran. Research and Practice in Thrombosis and Haemostasis. 7(4). 100179–100179. 23 indexed citations

Croteau, Stacy E.. (2022). Hemophilia A/B. Hematology/Oncology Clinics of North America. 36(4). 797–812. 2 indexed citations

Astermark, Jan, Katharina Holstein, Susan Kearney, et al.. (2021). The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B. Haemophilia. 27(5). 802–813. 10 indexed citations

Jaffray, Julie, Arash Mahajerin, Brian R. Branchford, et al.. (2021). A New Risk Assessment Model for Hospital-Acquired Venous Thromboembolism in Critically Ill Children: A Report From the Children’s Hospital-Acquired Thrombosis Consortium. Pediatric Critical Care Medicine. 23(1). e1–e9. 16 indexed citations

Jaffray, Julie, Brian R. Branchford, Neil A. Goldenberg, et al.. (2020). Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis Consortium. The Journal of Pediatrics. 228. 252–259.e1. 25 indexed citations

10.

Malec, Lynn, Dunlei Cheng, Char Witmer, et al.. (2020). The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States. American Journal of Hematology. 95(8). 960–965. 22 indexed citations

11.

Neumeyer, Joseph, Ruei‐Zeng Lin, Kai Wang, et al.. (2019). Bioengineering hemophilia A–specific microvascular grafts for delivery of full-length factor VIII into the bloodstream. Blood Advances. 3(24). 4166–4176. 14 indexed citations

12.

Iorio, Alfonso, Monika Maas Enriquez, Heinz Delesen, et al.. (2019). Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A. Blood. 134(Supplement_1). 3637–3637. 1 indexed citations

13.

Malec, Lynn, Stacy E. Croteau, Michael U. Callaghan, et al.. (2019). Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers. Blood. 134(Supplement_1). 2407–2407. 6 indexed citations

14.

Chelle, Pierre, Cindy H. T. Yeung, Stacy E. Croteau, et al.. (2019). Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup. Clinical Pharmacokinetics. 59(2). 245–256. 18 indexed citations

15.

Ragni, Margaret V., Stacy E. Croteau, Massimo Morfini, Marjon H. Cnossen, & Alfonso Iorio. (2018). Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 16(7). 1437–1441. 44 indexed citations

16.

Croteau, Stacy E., Michael J. Callaghan, Joanna A. Davis, et al.. (2018). Focusing in on use of pharmacokinetic profiles in routine hemophilia care. Research and Practice in Thrombosis and Haemostasis. 2(3). 607–614. 13 indexed citations

17.

Kruse‐Jarres, Rebecca, Michael U. Callaghan, Stacy E. Croteau, et al.. (2017). Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2). Blood. 130(Suppl_1). 89–89. 43 indexed citations

18.

Croteau, Stacy E., Charles Nakar, Ellis J. Neufeld, Amy D. Shapiro, & David L. Cooper. (2016). Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. Pediatric Blood & Cancer. 63(10). 1822–1828. 6 indexed citations

19.

Croteau, Stacy E., Hongyuan Luo, Leslie Lehmann, David H.K. Chui, & Ellis J. Neufeld. (2013). Novel dominant β‐thalassemia: Hb Boston‐Kuwait [Codon 139/140(+T)]. Pediatric Blood & Cancer. 60(10). E131–4. 8 indexed citations

20.

Croteau, Stacy E., Marilyn G. Liang, Harry P. Kozakewich, et al.. (2012). Kaposiform Hemangioendothelioma: Atypical Features and Risks of Kasabach-Merritt Phenomenon in 107 Referrals. The Journal of Pediatrics. 162(1). 142–147. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact